SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating) was the recipient of unusually large options trading on Wednesday. Stock investors acquired 1,200 call options on the company. This represents an increase of 1,438% compared to the typical volume of 78 call options.
SIGA Technologies Price Performance
Shares of SIGA opened at $10.86 on Thursday. The company has a market cap of $793.04 million, a PE ratio of 11.31 and a beta of 0.67. SIGA Technologies has a one year low of $5.84 and a one year high of $26.99. The stock has a 50-day moving average of $17.31 and a 200-day moving average of $11.91.
SIGA Technologies (NASDAQ:SIGA – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.03 EPS for the quarter. SIGA Technologies had a net margin of 48.67% and a return on equity of 48.79%. The company had revenue of $16.67 million for the quarter. Analysts expect that SIGA Technologies will post 0.66 EPS for the current fiscal year.
Institutional Inflows and Outflows
About SIGA Technologies
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.
- Get a free copy of the StockNews.com research report on SIGA Technologies (SIGA)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.